You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 1339 ALD2510: next generation Fc-enhanced, TREG-selective and IL-2-sparing anti-CD25 antibody with promising potential for the treatment of gynecological cancers

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1339 ALD2510: next generation Fc-enhanced, TREG-selective and IL-2-sparing anti-CD25 antibody with promising potential for the treatment of gynecological cancers
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022198021
Dec 20223407
Jan 20233606
Feb 20232404
Mar 20234607
Apr 20234605
May 20232405
Jun 20232002
Jul 20231004
Aug 20231800
Sep 20231205
Oct 20232802
Nov 20233205
Dec 20234006
Jan 20242801
Feb 20242405
Mar 202464012
Apr 20242204
May 20241602
Jun 20243104
Jul 20243204
Aug 20243404
Sep 20243001
Total8490116